Author:
Karalus N. C.,Garrett J. E.,Lang S. D. R.,Leng R. A.,Kostalas G. N.,Cursons R. T. M.,Cooper B. C.,Ryan C. J.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. Lassman, H. B., Puri, S. K., Ho, I., Sabo, R., Mezzino, M. J.: Pharmacokinetics of roxithromycin. J. Clin. Pharmacol. 28 (1988) 141–152.
2. Mac Donald, P.: New approaches to the management of community acquired pneumonia. JAMA 3 (SEA) (Suppl.) (1990) 14–19.
3. Young, R. A., Gonzalez, J. P., Sorkin, E. M.: Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37 (1989) 8–41.
4. Todd, P. A., Benfield, P.: Amoxycillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 39 (1990) 264–307.
5. Graham, V. A. L., Lowes, J. A. Shaw, E. J. Davies, R. J. The value of Augmentin in the management of RTI. Augmentin: Proc. Int. Symp., Montreux, Switzerland, July 1981,Leight, D. A. andRobinson, O. P. W. (eds.): Excerpta Medica, pp. 138–148.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献